BridgeMD
New treatment option for Knee Osteoarthritis
Official title Effects of Voodoo Flossing Technique in Knee Osteoarthritis Patients
ClinicalTrials.gov ID: NCT06986694
What this study is testing
- What it's testing
- Knee osteoarthritis (KOA) is a prevalent degenerative joint disease characterized by pain, stiffness, and reduced physical function, significantly impacting quality of life especially in elderly population. This study aims to evaluating the effectiveness of an emerging technique, known as 'Voodoo Flossing' on pain, range of motion and physical function in KOA to provide evidence-based insight of voodoo flossing as a potential therapeutic adjunct in KOA management.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 65
You may be able to join if
- Age ≥ 45 and ≤ 65
- Both Male and Female
- Knee Pain persisting for at-least 3 months
- Pain severity during walking ≥ 2/10 on a Numeric Pain Rating Scale
- Walking and Balance (Mobility) problems according to Time Up \& Go (TUG) test
You likely can't join if
- Age \ 65
- Severe Knee pain during Walking ≥ 9/10 on a Numeric Pain Rating Scale
- Knee OA Grade I, III \& IV (according to Kellgren-Lawrence method)
- Physical or Mental co-morbidity severely affecting daily life of patient
- Any Contraindication to provide Exercise Therapy
- Suspicion of chronic widespread pain (i.e., pain present for at least 3 months in at least three joints including left and right side of the body...
See the full eligibility criteria
- Age ≥ 45 and ≤ 65
- Both Male and Female
- Knee Pain persisting for at-least 3 months
- Pain severity during walking ≥ 2/10 on a Numeric Pain Rating Scale
- Walking and Balance (Mobility) problems according to Time Up \& Go (TUG) test
- Poor scoring on WOMAC scale for pain, stiffness and physical activities
- Knee OA Grade II (according to Kellgren-Lawrence method)
- Participants must provide informed consent for participation in RCT
- Age \ 65
- Severe Knee pain during Walking ≥ 9/10 on a Numeric Pain Rating Scale
- Knee OA Grade I, III \& IV (according to Kellgren-Lawrence method)
- Physical or Mental co-morbidity severely affecting daily life of patient
- Any Contraindication to provide Exercise Therapy
- Suspicion of chronic widespread pain (i.e., pain present for at least 3 months in at least three joints including left and right side of the body, above and below the waist, and the axial skeleton)
- Participant undergone total knee arthroplasty or on waiting list for total knee arthroplasty in any knee
- Any other reasons for knee pain than knee OA (e.g., rheumatoid arthritis and gout)
- Received intraarticular injections in past 6 months because of knee pain (Hyaluronic Gel or steroid)
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.